The problem of identification of prognostic factors for persistent trophoblastic disease
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 30 (1) , 57-62
- https://doi.org/10.1016/0090-8258(88)90046-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Prophylactic chemotherapy for hydatidiform mole five to 15 years follow-upCancer, 1986
- Gestational trophoblastic disease in women aged 50 or moreGynecologic Oncology, 1985
- MANAGEMENT OF GESTATIONAL TROPHOBLASTIC DISEASE - RESULTS OF A COOPERATIVE STUDY1982
- AN ANALYSIS OF THE INFLUENCES OF MATERNAL AGE, GESTATIONAL AGE, CONTRACEPTIVE METHOD, AND THE MODE OF PRIMARY TREATMENT OF PATIENTS WITH HYDATIDIFORM MOLES ON THE INCIDENCE OF SUBSEQUENT CHEMOTHERAPYBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- Clinical and laboratory correlates of molar pregnancy and trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1977
- ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIESAmerican Journal of Epidemiology, 1976
- FOLLOW‐UP AFTER HYDATlDIFORM MOLE: STUDIES USING RADIOIMMUNOASSAY FOR URINARY HUMAN CHORIONIC GONADOTROPHIN (HCG)BJOG: An International Journal of Obstetrics and Gynaecology, 1973
- ABO BLOOD-GROUPS IN TROPHOBLASTIC NEOPLASIAThe Lancet, 1971
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel ProcedureJournal of the American Statistical Association, 1963